Gut dysbiosis and neuroimmune responses to brain infection with Theiler's murine encephalomyelitis virus

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Carrillo Salinas, F J ^a,b   Mestre, L ^a,b   Mecha, M ^a,b   Feliu A ^a,b   Del Campo, R ^c   Villarrubia, N ^c   Espejo, C ^b,d,e   Montalban X ^b,d,e   Alvarez Cermeno J C ^b,f   Villar, L M ^b,c   Guaza, C ^a,b  

^a INSTITUTO CAJAL   (Spain)

^b Red Española de Esclerosis Múltiple ^*  (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^f UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BRAIN; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DYSBIOSIS; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; INTESTINE FLORA; LYMPH NODE; LYMPHOCYTE ACTIVATION; MICROBIOLOGY; MOUSE; MULTIPLE SCLEROSIS; PATHOGENICITY; PATHOLOGY; PATHOPHYSIOLOGY; SPINAL CORD; THEILOVIRUS; VIROLOGY;

ANIMALS; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DYSBIOSIS; GASTROINTESTINAL MICROBIOME; HUMANS; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MULTIPLE SCLEROSIS; NEUROIMMUNOMODULATION; SPINAL CORD; THEILOVIRUS;

EID: 85015267679     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep44377     Document Type: Article

References (68)

1. Lassmann, H. et al. Pathology and disease mechanisms in different stages of multiple sclerosis. J Neurol Sci 333, 1-4 (2013).
2. Ferguson, B., Matyszak, M. K., Esiri, M. M. & Perry, V. H. Axonal damage in acute multiple sclerosis lesions. Brain 120 (Pt 3), 393-399 (1997).
3. Trapp, B. D. et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338, 278-285 (1998).
4. Koch, M. W., Metz, L. M., Agrawal, S. M., Yong, V. W. & Lipton, H. L. Environmental factors and their regulation of immunity in multiple sclerosis J Neurol Sci 324, 10-16 (2013).
5. Wang, Y. & Kasper, L. H. The role of microbiome in central nervous system disorders. Brain Behav Immun 38, 1-12 (2014).
6. Ochoa-Reparaz, J. et al. Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J Immunol 183, 6041-6050 (2009).
7. Olszak, T. et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 336, 489-493 (2012).
8. Round, J. L. & Mazmanian, S. K. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci USA 107, 12204-12209 (2010).
9. OMahony, C. et al. Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation. PLoS Pathog 4, e1000112 (2008).
10. Berer, K. & Krishnamoorthy, G. Commensal gut flora and brain autoimmunity: a love or hate affair? Acta Neuropathol 123, 639-651 (2012).
11. Banati, M. et al. Antibody response against gastrointestinal antigens in demyelinating diseases of the central nervous system. Eur J Neurol 20, 1492-1495 (2013).
12. Berer, K. et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479, 538-541 (2011).
13. Lee, Y. K., Menezes, J. S., Umesaki, Y. & Mazmanian, S. K. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 108 Suppl 1, 4615-4622 (2011).
14. Yokote, H. et al. NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora. Am J Pathol 173, 1714-1723 (2008).
15. Pang, I. K. & Iwasaki, A. Control of antiviral immunity by pattern recognition and the microbiome. Immunol Rev 245, 209-226 (2012).
16. Kane, M. et al. Successful transmission of a retrovirus depends on the commensal microbiota. Science 334, 245-249 (2011).
17. Kuss, S. K. et al. Intestinal microbiota promote enteric virus replication and systemic pathogenesis. Science 334, 249-252 (2011).
18. Lipton, H. L. Theilers virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect Immun 11, 1147-1155 (1975).
19. Mecha, M., Carrillo-Salinas, F. J., Mestre, L., Feliu, A. & Guaza, C. Viral models of multiple sclerosis: neurodegeneration and demyelination in mice infected with Theilers virus. Prog Neurobiol 101-102, 46-64 (2013).
20. Miller, S. D., Olson, J. K. & Croxford, J. L. Multiple pathways to induction of virus-induced autoimmune demyelination: lessons from Theilers virus infection. J Autoimmun 16, 219-227 (2001).
21. Tselis, A. Evidence for viral etiology of multiple sclerosis. Semin Neurol 31, 307-316 (2011).
22. Hill, D. A. et al. Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis. Mucosal Immunol 3, 148-158 (2010).
23. Ichinohe, T. et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc Natl Acad Sci USA 108, 5354-5359 (2011).
24. Olson, J. K. & Miller, S. D. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 173, 3916-3924 (2004).
25. Mestre, L. et al. A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules. Mol Cell Neurosci 40, 258-266 (2009).
26. McMahon, E. J., Bailey, S. L., Castenada, C. V., Waldner, H. & Miller, S. D. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat Med 11, 335-339 (2005).
27. Mecha, M. et al. Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors. Neurobiol Dis 59, 141-150 (2013).
28. Correa, F. et al. The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells. Brain Behav Immun 25, 736-749 (2011).
29. Gilli, F., Li, L. & Pachner, A. R. The immune response in the CNS in Theilers virus induced demyelinating disease switches from an early adaptive response to a chronic innate-like response. J Neurovirol 22, 66-79, doi: 10.1007/s13365-015-0369-4 (2016).
30. Mestre, L. et al. PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosis. Br J Pharmacol 172, 4277-4290 (2015).
31. McGavern, D. B., Zoecklein, L., Sathornsumetee, S. & Rodriguez, M. Assessment of hindlimb gait as a powerful indicator of axonal loss in a murine model of progressive CNS demyelination. Brain Res 877, 396-400 (2000).
32. Collins, S. M., Surette, M. & Bercik, P. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol 10, 735-742 (2012).
33. Mielcarz, D. W. & Kasper, L. H. The gut microbiome in multiple sclerosis. Curr Treat Options Neurol 17, 344 (2015).
34. Jangi, S. et al. Alterations of the human gut microbiome in multiple sclerosis. Nat Commun 7, 12015 (2016).
35. Swidsinski, A. et al. Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum. Gut 60, 34-40 (2011).
36. Zhang, H. et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci USA 106, 2365-2370 (2009).
37. Wang, L. et al. Low relative abundances of the mucolytic bacterium Akkermansia muciniphila and Bifidobacterium spp. in feces of children with autism. Appl Environ Microbiol 77, 6718-6721 (2011).
38. Scher, J. U. et al. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol 67, 128-139 (2015).
39. Lam, Y. Y. et al. Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS One 7, e34233 (2012).
40. Percy, D. H. B. & S. W. In Pathology of Laboratory Rodents and Rabbits 3-106 (Ames, 2001).
41. Hakansson, A. & Molin, G. Gut microbiota and inflammation. Nutrients 3, 637-682 (2011).
42. Miyake, S. et al. Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters. PLoS One 10, e0137429 (2015).
43. Nouri, M., Bredberg, A., Westrom, B. & Lavasani, S. Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cells. PLoS One 9, e106335 (2014).
44. Ochoa-Reparaz, J., Mielcarz, D. W., Begum-Haque, S. & Kasper, L. H. Gut, bugs, and brain: role of commensal bacteria in the control of central nervous system disease. Ann Neurol 69, 240-247 (2011).
45. Mishra, M. K. & Yong, V. W. Myeloid cells -targets of medication in multiple sclerosis. Nat Rev Neurol 12, 539-551 (2016).
46. Olson, J. K. & Miller, S. D. The innate immune response affects the development of the autoimmune response in Theilers virusinduced demyelinating disease. J Immunol 182, 5712-5722 (2009).
47. Pachner, A. R., Li, L. & Gilli, F. Chemokine biomarkers in central nervous system tissue and cerebrospinal fluid in the Theilers virus model mirror those in multiple sclerosis. Cytokine 76, 577-580 (2015).
48. Opdenakker, G., Proost, P. & Van Damme, J. Microbiomic and Posttranslational Modifications as Preludes to Autoimmune Diseases. Trends Mol Med 22, 746-757 (2016).
49. Scarisbrick, I. A. et al. Kallikrein 6 regulates early CNS demyelination in a viral model of multiple sclerosis. Brain Pathol 22, 709-722 (2012).
50. Erny, D. et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci 18, 965-977 (2015).
51. Tsunoda, I., Tanaka, T., Saijoh, Y. & Fujinami, R. S. Targeting inflammatory demyelinating lesions to sites of Wallerian degeneration. Am J Pathol 171, 1563-1575 (2007).
52. Abt, M. C. et al. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 37, 158-170 (2012).
53. Mendez-Fernandez, Y. V., Hansen, M. J., Rodriguez, M. & Pease, L. R. Anatomical and cellular requirements for the activation and migration of virus-specific CD8+ T cells to the brain during Theilers virus infection. J Virol 79, 3063-3070 (2005).
54. Mann, E. R. & Li, X. Intestinal antigen-presenting cells in mucosal immune homeostasis: crosstalk between dendritic cells, macrophages and B-cells. World J Gastroenterol 20, 9653-9664 (2014).
55. Kleinewietfeld, M. & Hafler, D. A. Regulatory T cells in autoimmune neuroinflammation. Immunol Rev 259 (2014).
56. Veiga-Parga, T., Sehrawat, S. & Rouse, B. T. Role of regulatory T cells during virus infection. Immunol Rev 255, 182-196 (2013).
57. Martinez, N. E. et al. Protective and detrimental roles for regulatory T cells in a viral model for multiple sclerosis. Brain Pathol 24, 436-451 (2014).
58. Richards, M. H. et al. Virus expanded regulatory T cells control disease severity in the Theilers virus mouse model of MS. J Autoimmun 36, 142-154 (2011).
59. McGeachy, M. J., Stephens, L. A. & Anderton, S. M. Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+ CD25+ regulatory cells within the central nervous system. J Immunol 175, 3025-3032 (2005).
60. Herder, V. et al. Interleukin-10 expression during the acute phase is a putative prerequisite for delayed viral elimination in a murine model for multiple sclerosis. J Neuroimmunol 249, 27-39 (2012).
61. Lledo, A., Borrell, J. & Guaza, C. Dexamethasone regulation of interleukin-1-receptors in the hippocampus of Theilers virusinfected mice: effects on virus-mediated demyelination. Eur J Pharmacol 372, 75-83 (1999).
62. Klindworth, A. et al. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencingbased diversity studies. Nucleic Acids Res 41, e1 (2013).
63. Arevalo-Martin, A., Molina-Holgado, E. & Guaza, C. A CB(1)/CB(2) receptor agonist, WIN 55, 212-2, exerts its therapeutic effect in a viral autoimmune model of multiple sclerosis by restoring self-tolerance to myelin. Neuropharmacology 63, 385-393 (2012).
64. Denic, A. et al. A single dose of neuron-binding human monoclonal antibody improves spontaneous activity in a murine model of demyelination. PLoS One 6, e26001 (2011).
65. Sarkar, D., Le Meur, N. & Gentleman, R. Using flowViz to visualize flow cytometry data. Bioinformatics 24, 878-879 (2008).
66. Allaire, J., Horner, J., M. V. & Porte, N. Markdown: Markdown rendering for R. R package version 0.6.4. (2014).
67. C, B. Knitcitations: Citations for knitr markdown files. R package version 1.0-1. http://github.com/cboettig/knitcitations (2014).
68. Xie, Y. In Implementing Reproducible Computational Research (ed. Victoria; Leisch Stodden, Friedrich; Peng, Roger D) (2014).